表紙
市場調査レポート

ImQuest Life Sciences:製品パイプライン分析

ImQuest Life Sciences - Product Pipeline Review - 2015

発行 Global Markets Direct 商品コード 192654
出版日 ページ情報 英文 27 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.06円で換算しております。
Back to Top
ImQuest Life Sciences:製品パイプライン分析 ImQuest Life Sciences - Product Pipeline Review - 2015
出版日: 2015年07月15日 ページ情報: 英文 27 Pages
概要

ImQuest Life Sciencesは、感染症、癌、炎症性疾患向け治療薬の開発に注力している医薬品製造会社です。

当レポートでは、ImQuest Life Sciencesにおける治療薬開発パイプラインの現況と各開発段階の比較分析、薬剤標的、作用機序、投与経路、分子タイプ別の治療薬の評価、最新の企業ニュースや発表、後期段階および中止されたプロジェクトに関する情報などを提供しています。

ImQuest Life Sciencesの基本情報

  • ImQuest Life Sciencesの概要
  • 主要情報
  • 企業情報

ImQuest Life Sciences:R&Dの概要

  • 主な治療範囲

ImQuest Life Sciences:パイプラインのレビュー

  • 開発段階別のパイプライン製品
  • 単剤製品

ImQuest Life Sciences:パイプライン製品の概況

  • 初期段階にあるパイプライン製品
    • IND/CTA 出願製品/併用療法モダリティ
    • 前臨床段階にある製品/併用療法モダリティ
    • 創薬中の製品/併用療法モダリティ

ImQuest Life Sciences:薬剤プロファイル

  • IQP-0528
  • IQP-0410
  • IQP-1187
  • IQP-1960
  • 炎症性疾患治療薬

ImQuest Life Sciences:パイプライン分析

  • 標的別
  • 投与経路別
  • 分子タイプ別
  • 作用機序別

ImQuest Life Sciences:最新のパイプライン動向

ImQuest Life Sciences:休止中のプロジェクト

ImQuest Life Sciences:本社と子会社の所在地

付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GMDHC07314CDB

Summary

Global Markets Direct's, 'ImQuest Life Sciences - Product Pipeline Review - 2015', provides an overview of the ImQuest Life Sciences's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of ImQuest Life Sciences's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of ImQuest Life Sciences including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of ImQuest Life Sciences's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the ImQuest Life Sciences's pipeline products

Reasons to buy

  • Evaluate ImQuest Life Sciences's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of ImQuest Life Sciences in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the ImQuest Life Sciences's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of ImQuest Life Sciences and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of ImQuest Life Sciences
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of ImQuest Life Sciences and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • ImQuest Life Sciences Snapshot
    • ImQuest Life Sciences Overview
    • Key Information
    • Key Facts
  • ImQuest Life Sciences - Research and Development Overview
    • Key Therapeutic Areas
  • ImQuest Life Sciences - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • ImQuest Life Sciences - Pipeline Products Glance
    • ImQuest Life Sciences - Early Stage Pipeline Products
      • IND/CTA Filed Products/Combination Treatment Modalities
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • ImQuest Life Sciences - Drug Profiles
    • IQP-0528
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • IQP-0410
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • IQP-1187
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • IQP-1960
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Drug for Inflammatory Disease
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • ImQuest Life Sciences - Pipeline Analysis
    • ImQuest Life Sciences - Pipeline Products by Target
    • ImQuest Life Sciences - Pipeline Products by Route of Administration
    • ImQuest Life Sciences - Pipeline Products by Molecule Type
    • ImQuest Life Sciences - Pipeline Products by Mechanism of Action
  • ImQuest Life Sciences - Recent Pipeline Updates
  • ImQuest Life Sciences - Dormant Projects
  • ImQuest Life Sciences - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • ImQuest Life Sciences, Key Information
  • ImQuest Life Sciences, Key Facts
  • ImQuest Life Sciences - Pipeline by Indication, 2015
  • ImQuest Life Sciences - Pipeline by Stage of Development, 2015
  • ImQuest Life Sciences - Monotherapy Products in Pipeline, 2015
  • ImQuest Life Sciences - IND/CTA Filed, 2015
  • ImQuest Life Sciences - Preclinical, 2015
  • ImQuest Life Sciences - Discovery, 2015
  • ImQuest Life Sciences - Pipeline by Target, 2015
  • ImQuest Life Sciences - Pipeline by Route of Administration, 2015
  • ImQuest Life Sciences - Pipeline by Molecule Type, 2015
  • ImQuest Life Sciences - Pipeline Products by Mechanism of Action, 2015
  • ImQuest Life Sciences - Recent Pipeline Updates, 2015
  • ImQuest Life Sciences - Dormant Developmental Projects,2015

List of Figures

  • ImQuest Life Sciences - Pipeline by Top 10 Indication, 2015
  • ImQuest Life Sciences - Pipeline by Stage of Development, 2015
  • ImQuest Life Sciences - Monotherapy Products in Pipeline, 2015
  • ImQuest Life Sciences - Pipeline by Top 10 Target, 2015
  • ImQuest Life Sciences - Pipeline by Top 10 Route of Administration, 2015
  • ImQuest Life Sciences - Pipeline by Top 10 Molecule Type, 2015
  • ImQuest Life Sciences - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top